Global Beta-lactam and Beta-lactamase Inhibitors Market Size, Status and Forecast 2024-2031

Report ID: 934235 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Penicillin
        1.2.3 Cephalosporin
        1.2.4 Carbapenem
        1.2.5 Monobactam
        1.2.6 Combination
    1.3 Market by Application
        1.3.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Oral
        1.3.3 Intravenous
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Perspective (2016-2027)
    2.2 Beta-lactam and Beta-lactamase Inhibitors Growth Trends by Regions
        2.2.1 Beta-lactam and Beta-lactamase Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Beta-lactam and Beta-lactamase Inhibitors Historic Market Share by Regions (2016-2021)
        2.2.3 Beta-lactam and Beta-lactamase Inhibitors Forecasted Market Size by Regions (2022-2027)
    2.3 Beta-lactam and Beta-lactamase Inhibitors Industry Dynamic
        2.3.1 Beta-lactam and Beta-lactamase Inhibitors Market Trends
        2.3.2 Beta-lactam and Beta-lactamase Inhibitors Market Drivers
        2.3.3 Beta-lactam and Beta-lactamase Inhibitors Market Challenges
        2.3.4 Beta-lactam and Beta-lactamase Inhibitors Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Beta-lactam and Beta-lactamase Inhibitors Players by Revenue
        3.1.1 Global Top Beta-lactam and Beta-lactamase Inhibitors Players by Revenue (2016-2021)
        3.1.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Players (2016-2021)
    3.2 Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Beta-lactam and Beta-lactamase Inhibitors Revenue
    3.4 Global Beta-lactam and Beta-lactamase Inhibitors Market Concentration Ratio
        3.4.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Beta-lactam and Beta-lactamase Inhibitors Revenue in 2020
    3.5 Beta-lactam and Beta-lactamase Inhibitors Key Players Head office and Area Served
    3.6 Key Players Beta-lactam and Beta-lactamase Inhibitors Product Solution and Service
    3.7 Date of Enter into Beta-lactam and Beta-lactamase Inhibitors Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Beta-lactam and Beta-lactamase Inhibitors Breakdown Data by Type
    4.1 Global Beta-lactam and Beta-lactamase Inhibitors Historic Market Size by Type (2016-2021)
    4.2 Global Beta-lactam and Beta-lactamase Inhibitors Forecasted Market Size by Type (2022-2027)

5 Beta-lactam and Beta-lactamase Inhibitors Breakdown Data by Application
    5.1 Global Beta-lactam and Beta-lactamase Inhibitors Historic Market Size by Application (2016-2021)
    5.2 Global Beta-lactam and Beta-lactamase Inhibitors Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Beta-lactam and Beta-lactamase Inhibitors Market Size (2016-2027)
    6.2 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type
        6.2.1 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021)
        6.2.2 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027)
        6.2.3 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2027)
    6.3 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application
        6.3.1 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021)
        6.3.2 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027)
        6.3.3 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2027)
    6.4 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country
        6.4.1 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2016-2021)
        6.4.2 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size (2016-2027)
    7.2 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Type
        7.2.1 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021)
        7.2.2 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027)
        7.2.3 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2027)
    7.3 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Application
        7.3.1 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021)
        7.3.2 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027)
        7.3.3 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2027)
    7.4 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Country
        7.4.1 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2016-2021)
        7.4.2 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size (2016-2027)
    8.2 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Type
        8.2.1 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2027)
    8.3 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Application
        8.3.1 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2027)
    8.4 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Region
        8.4.1 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size (2016-2027)
    9.2 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type
        9.2.1 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021)
        9.2.2 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027)
        9.2.3 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2027)
    9.3 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application
        9.3.1 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021)
        9.3.2 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027)
        9.3.3 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2027)
    9.4 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country
        9.4.1 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2016-2021)
        9.4.2 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size (2016-2027)
    10.2 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Type
        10.2.1 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2027)
    10.3 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Application
        10.3.1 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2027)
    10.4 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Country
        10.4.1 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Details
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Beta-lactam and Beta-lactamase Inhibitors Introduction
        11.1.4 Abbott Laboratories Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
        11.1.5 Abbott Laboratories Recent Development
    11.2 Allergan Plc.
        11.2.1 Allergan Plc. Company Details
        11.2.2 Allergan Plc. Business Overview
        11.2.3 Allergan Plc. Beta-lactam and Beta-lactamase Inhibitors Introduction
        11.2.4 Allergan Plc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
        11.2.5 Allergan Plc. Recent Development
    11.3 F. Hoffmann-La Roche Ltd.
        11.3.1 F. Hoffmann-La Roche Ltd. Company Details
        11.3.2 F. Hoffmann-La Roche Ltd. Business Overview
        11.3.3 F. Hoffmann-La Roche Ltd. Beta-lactam and Beta-lactamase Inhibitors Introduction
        11.3.4 F. Hoffmann-La Roche Ltd. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
        11.3.5 F. Hoffmann-La Roche Ltd. Recent Development
    11.4 GlaxoSmithKline plc
        11.4.1 GlaxoSmithKline plc Company Details
        11.4.2 GlaxoSmithKline plc Business Overview
        11.4.3 GlaxoSmithKline plc Beta-lactam and Beta-lactamase Inhibitors Introduction
        11.4.4 GlaxoSmithKline plc Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
        11.4.5 GlaxoSmithKline plc Recent Development
    11.5 Merck & Co. Inc.
        11.5.1 Merck & Co. Inc. Company Details
        11.5.2 Merck & Co. Inc. Business Overview
        11.5.3 Merck & Co. Inc. Beta-lactam and Beta-lactamase Inhibitors Introduction
        11.5.4 Merck & Co. Inc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
        11.5.5 Merck & Co. Inc. Recent Development
    11.6 Mylan N.V.
        11.6.1 Mylan N.V. Company Details
        11.6.2 Mylan N.V. Business Overview
        11.6.3 Mylan N.V. Beta-lactam and Beta-lactamase Inhibitors Introduction
        11.6.4 Mylan N.V. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
        11.6.5 Mylan N.V. Recent Development
    11.7 Novartis International AG (Sandoz)
        11.7.1 Novartis International AG (Sandoz) Company Details
        11.7.2 Novartis International AG (Sandoz) Business Overview
        11.7.3 Novartis International AG (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Introduction
        11.7.4 Novartis International AG (Sandoz) Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
        11.7.5 Novartis International AG (Sandoz) Recent Development
    11.8 Pfizer Inc.
        11.8.1 Pfizer Inc. Company Details
        11.8.2 Pfizer Inc. Business Overview
        11.8.3 Pfizer Inc. Beta-lactam and Beta-lactamase Inhibitors Introduction
        11.8.4 Pfizer Inc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
        11.8.5 Pfizer Inc. Recent Development
    11.9 Sanofi
        11.9.1 Sanofi Company Details
        11.9.2 Sanofi Business Overview
        11.9.3 Sanofi Beta-lactam and Beta-lactamase Inhibitors Introduction
        11.9.4 Sanofi Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
        11.9.5 Sanofi Recent Development
    11.10 Teva Pharmaceutical Industries Ltd
        11.10.1 Teva Pharmaceutical Industries Ltd Company Details
        11.10.2 Teva Pharmaceutical Industries Ltd Business Overview
        11.10.3 Teva Pharmaceutical Industries Ltd Beta-lactam and Beta-lactamase Inhibitors Introduction
        11.10.4 Teva Pharmaceutical Industries Ltd Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
        11.10.5 Teva Pharmaceutical Industries Ltd Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Penicillin
    Table 3. Key Players of Cephalosporin
    Table 4. Key Players of Carbapenem
    Table 5. Key Players of Monobactam
    Table 6. Key Players of Combination
    Table 7. Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Regions (2016-2021)
    Table 11. Global Beta-lactam and Beta-lactamase Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Regions (2022-2027)
    Table 13. Beta-lactam and Beta-lactamase Inhibitors Market Trends
    Table 14. Beta-lactam and Beta-lactamase Inhibitors Market Drivers
    Table 15. Beta-lactam and Beta-lactamase Inhibitors Market Challenges
    Table 16. Beta-lactam and Beta-lactamase Inhibitors Market Restraints
    Table 17. Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Players (2016-2021)
    Table 19. Global Top Beta-lactam and Beta-lactamase Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Beta-lactam and Beta-lactamase Inhibitors as of 2020)
    Table 20. Ranking of Global Top Beta-lactam and Beta-lactamase Inhibitors Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Beta-lactam and Beta-lactamase Inhibitors Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Beta-lactam and Beta-lactamase Inhibitors Product Solution and Service
    Table 24. Date of Enter into Beta-lactam and Beta-lactamase Inhibitors Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Type (2016-2021)
    Table 28. Global Beta-lactam and Beta-lactamase Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Beta-lactam and Beta-lactamase Inhibitors Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Application (2016-2021)
    Table 32. Global Beta-lactam and Beta-lactamase Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Abbott Laboratories Company Details
    Table 65. Abbott Laboratories Business Overview
    Table 66. Abbott Laboratories Beta-lactam and Beta-lactamase Inhibitors Product
    Table 67. Abbott Laboratories Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
    Table 68. Abbott Laboratories Recent Development
    Table 69. Allergan Plc. Company Details
    Table 70. Allergan Plc. Business Overview
    Table 71. Allergan Plc. Beta-lactam and Beta-lactamase Inhibitors Product
    Table 72. Allergan Plc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
    Table 73. Allergan Plc. Recent Development
    Table 74. F. Hoffmann-La Roche Ltd. Company Details
    Table 75. F. Hoffmann-La Roche Ltd. Business Overview
    Table 76. F. Hoffmann-La Roche Ltd. Beta-lactam and Beta-lactamase Inhibitors Product
    Table 77. F. Hoffmann-La Roche Ltd. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
    Table 78. F. Hoffmann-La Roche Ltd. Recent Development
    Table 79. GlaxoSmithKline plc Company Details
    Table 80. GlaxoSmithKline plc Business Overview
    Table 81. GlaxoSmithKline plc Beta-lactam and Beta-lactamase Inhibitors Product
    Table 82. GlaxoSmithKline plc Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
    Table 83. GlaxoSmithKline plc Recent Development
    Table 84. Merck & Co. Inc. Company Details
    Table 85. Merck & Co. Inc. Business Overview
    Table 86. Merck & Co. Inc. Beta-lactam and Beta-lactamase Inhibitors Product
    Table 87. Merck & Co. Inc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
    Table 88. Merck & Co. Inc. Recent Development
    Table 89. Mylan N.V. Company Details
    Table 90. Mylan N.V. Business Overview
    Table 91. Mylan N.V. Beta-lactam and Beta-lactamase Inhibitors Product
    Table 92. Mylan N.V. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
    Table 93. Mylan N.V. Recent Development
    Table 94. Novartis International AG (Sandoz) Company Details
    Table 95. Novartis International AG (Sandoz) Business Overview
    Table 96. Novartis International AG (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Product
    Table 97. Novartis International AG (Sandoz) Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
    Table 98. Novartis International AG (Sandoz) Recent Development
    Table 99. Pfizer Inc. Company Details
    Table 100. Pfizer Inc. Business Overview
    Table 101. Pfizer Inc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
    Table 102. Pfizer Inc. Recent Development
    Table 103. Sanofi Company Details
    Table 104. Sanofi Business Overview
    Table 105. Sanofi Beta-lactam and Beta-lactamase Inhibitors Product
    Table 106. Sanofi Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
    Table 107. Sanofi Recent Development
    Table 108. Teva Pharmaceutical Industries Ltd Company Details
    Table 109. Teva Pharmaceutical Industries Ltd Business Overview
    Table 110. Teva Pharmaceutical Industries Ltd Beta-lactam and Beta-lactamase Inhibitors Product
    Table 111. Teva Pharmaceutical Industries Ltd Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
    Table 112. Teva Pharmaceutical Industries Ltd Recent Development
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Type: 2020 VS 2027
    Figure 2. Penicillin Features
    Figure 3. Cephalosporin Features
    Figure 4. Carbapenem Features
    Figure 5. Monobactam Features
    Figure 6. Combination Features
    Figure 7. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Application: 2020 VS 2027
    Figure 8. Oral Case Studies
    Figure 9. Intravenous Case Studies
    Figure 10. Others Case Studies
    Figure 11. Beta-lactam and Beta-lactamase Inhibitors Report Years Considered
    Figure 12. Global Beta-lactam and Beta-lactamase Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Beta-lactam and Beta-lactamase Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Regions: 2020 VS 2027
    Figure 15. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Regions (2022-2027)
    Figure 16. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Players in 2020
    Figure 17. Global Top Beta-lactam and Beta-lactamase Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Beta-lactam and Beta-lactamase Inhibitors as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Beta-lactam and Beta-lactamase Inhibitors Revenue in 2020
    Figure 19. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Type (2016-2021)
    Figure 20. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Type (2022-2027)
    Figure 21. North America Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Beta-lactam and Beta-lactamase Inhibitors Market Share by Type (2016-2027)
    Figure 23. North America Beta-lactam and Beta-lactamase Inhibitors Market Share by Application (2016-2027)
    Figure 24. North America Beta-lactam and Beta-lactamase Inhibitors Market Share by Country (2016-2027)
    Figure 25. United States Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Beta-lactam and Beta-lactamase Inhibitors Market Share by Type (2016-2027)
    Figure 29. Europe Beta-lactam and Beta-lactamase Inhibitors Market Share by Application (2016-2027)
    Figure 30. Europe Beta-lactam and Beta-lactamase Inhibitors Market Share by Country (2016-2027)
    Figure 31. Germany Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Share by Region (2016-2027)
    Figure 41. China Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Share by Type (2016-2027)
    Figure 49. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Share by Application (2016-2027)
    Figure 50. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Share by Country (2016-2027)
    Figure 51. Mexico Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Share by Country (2016-2027)
    Figure 57. Turkey Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Abbott Laboratories Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
    Figure 61. Allergan Plc. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
    Figure 62. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
    Figure 63. GlaxoSmithKline plc Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
    Figure 64. Merck & Co. Inc. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
    Figure 65. Mylan N.V. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
    Figure 66. Novartis International AG (Sandoz) Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
    Figure 67. Pfizer Inc. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
    Figure 68. Sanofi Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
    Figure 69. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
Allergan Plc.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Merck & Co. Inc.
Mylan N.V.
Novartis International AG (Sandoz)
Pfizer Inc.
Sanofi
Teva Pharmaceutical Industries Ltd
Frequently Asked Questions
Beta-lactam and Beta-lactamase Inhibitors report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Beta-lactam and Beta-lactamase Inhibitors report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Beta-lactam and Beta-lactamase Inhibitors report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports